Follow-up outcomes of the minimalistic hybrid approach for chronic total occlusion percutaneous coronary intervention

Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) should be performed when the anticipated benefits outweigh the risks. The main benefit is symptom improvement: randomized controlled trials (RCTs) comparing CTO PCI with medical therapy showed that patients who undergo CTO PCI experience improvement of angina and dyspnea without reduction of the risk of follow-up clinical events, such as death and myocardial infarction.1-4 However, patients enrolled in CTO PCI RCTs have lower risk profiles and less complex CTOs than those in real-world registries, highlighting a potential limitation of those studies.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research